Answers are grounded in this paper and cite their sources.
Evaluates anticoagulant effects and endothelial cell behavior using synthetic polysulfates, suggesting potential for vascular applications.
We present a versatile method for fabricating glycosaminoglycan (GAG)‐inspired polyelectrolyte brush coatings from fully synthetic sulfated PHEMA block copolymers. Using a bioinert backbone enables evaluation of sulfation effects independently of natural GAGs’ carbohydrate backbone. A degree of sulfation above 70% imparted anticoagulant activity, extending plasma coagulation times beyond 500 s at 0.1 mg mL − 1 . Controlled self‐assembly enabled fabrication and photoimmobilization of uniform, nanometer‐thin brushes on polystyrene substrates. The polysulfate brushes exhibited molecular weight‐dependent properties: under serum‐free conditions, endothelial cells (HUVECs) selectively proliferated on longer P2 ‐OSO 3 ‐BP (65 kDa) compared to shorter P1 ‐OSO 3 ‐BP (15 kDa) brushes, while smooth muscle cells (SMCs) remained quiescent. Despite comparable VEGF and bFGF surface densities (0.5 ng cm −2 ), P2 ‐OSO 3 ‐BP coatings better preserved VEGF bioactivity, likely due to higher chain flexibility. In co‐culture under serum conditions (5%), HUVEC/SMC ratios remained near unity with persistent colocalization, indicating restrained SMC overgrowth and stabilized vascular co‐culture relevant to preventing neointimal hyperplasia. These findings highlight synthetic polysulfate brush coatings as a platform for studying sulfation‐driven growth factor interactions and vascular cell competition at biomaterial interfaces, promoting reendothelialization in vitro. The system therefore represents a functional mimetic of GAGs, reproducing key electrostatic features while avoiding the structural complexity of native polysaccharides.
No takes yet. Share an insight, caveat, or question.
Cosimi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: